Galectin Therapeutics Inc. (GALT) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Galectin Therapeutics Inc...

    NASDAQ: GALT · Real-Time Price · USD
    4.21
    -0.34 (-7.47%)
    At close: Sep 29, 2025, 3:26 PM

    Galectin Therapeutics Balance Sheet Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Cash & Equivalents
    		 15.12M 25.66M 18.59M 39.65M
    Short-Term Investments
    		 n/a n/a n/a n/a
    Long-Term Investments
    		 n/a n/a n/a n/a
    Other Long-Term Assets
    		 243K 437K 733K 7K
    Receivables
    		 n/a n/a n/a n/a
    Inventory
    		 n/a n/a n/a n/a
    Other Current Assets
    		 2.13M 2.05M 1.96M 2.17M
    Total Current Assets
    		 17.25M 27.71M 20.55M 41.82M
    Property-Plant & Equipment
    		 n/a 53K n/a n/a
    Goodwill & Intangibles
    		 n/a n/a n/a n/a
    Total Long-Term Assets
    		 243K 490K 733K 7K
    Total Assets
    		 17.5M 28.2M 21.29M 41.83M
    Account Payables
    		 5.66M 6.43M 3.89M 1.8M
    Deferred Revenue
    		 n/a n/a n/a n/a
    Short-Term Debt
    		 21.12M n/a n/a n/a
    Other Current Liabilities
    		 1.89M 8.07M 8.11M 6.49M
    Total Current Liabilities
    		 35.41M 15.68M 13.01M 9.03M
    Long-Term Debt
    		 85.11M 71.74M 39.83M 29.05M
    Other Long-Term Liabilities
    		 47K 1M 573K 1.13M
    Total Long-Term Liabilities
    		 85.16M 72.77M 40.47M 30.18M
    Total Liabilities
    		 120.56M 88.44M 53.48M 39.21M
    Total Debt
    		 106.25M 71.81M 39.87M 29.06M
    Book Value
    		 -103.07M -60.24M -32.19M 2.62M
    Book Value Per Share
    		 -1.65 -1 -0.54 0.04
    Common Stock
    		 62K 61K 59K 59K
    Retained Earnings
    		 -401.57M -354.37M -309.57M -270.69M
    Comprehensive Income
    		 n/a 0.00 n/a 0.00
    Shareholders Equity
    		 -103.07M -60.24M -32.19M 2.62M
    Total Investments
    		 n/a n/a n/a n/a

    Add to Watchlist